Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$50k
1 round on record
Latest round
$50k
Convertible Note · Sep 2026 · this month
The money's age
Fresh money
0 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 18 Raised a round Convertible Note $50k · SEC Form D 2024 Founded
Tractionpublic signals, read monthly
Hacker News stories
1
best: 2 points
Funding rounds
RoundDateAmountInvestorsSource
Convertible Note Sep 2026 $50k — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Pace Pharmaceuticals, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Douglas YaoExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Vico TherapeuticsFounded 2019 • 51-200 employees
Pioneering RNA-based science to target the root cause of rare genetic neurological diseases VO659: The first clinical candidate directly…
Aruna BioVenture round $13.3M · 7 yr ago • 51-200 employees
Unlocking new possibilities for millions with neurological disease.
Vanqua BioVenture round $45M · 2 yr ago • Founded 2019 • 201-500 employees
Our Mission. Deliver medicines that transform the lives of patients with neurodegenerative diseases.
Tetsuwan Scientific builds ResearchOS: a scientific-native language abstraction for lab automation and the key to the development of the…
NRG TherapeuticsVenture round · 7 mo ago • Founded 2018 • 201-500 employees
Restoring energy. Next-generation disease-modifying medicines for ALS and Parkinson's.
Monument BiosciencesVenture round $5.8M · 3 yr ago • Founded 2018 • 11-50 employees
Boldly advancing the next generation of medicines for Alzheimer’s Disease and Related Dementias.

Overview

Pace Pharmaceuticals integrates AI and laboratory robotics to develop new medicines for neurological disease. Explore our compounds and research.

People

Douglas Yao
Executive Officer, Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Cupertino United States
HQ

Financials

Total raised
$50k
Latest round
Convertible Note
Funding rounds
1
Funding rounds
Round Announced Amount
Convertible Note 2026 $50k Details